Skip to main content

6 Result(s)

within Meydan Ben Ishai Remove this filter

and

  1. Article

    Open Access

    Aflibercept clearance through the drainage system in a rat model

    As intravitreal anti-VEGF injections became the mainstay of treatment for many retinal diseases, the cause of a secondary sustained elevated intraocular pressure is still unclear. The aim of our study was to s...

    Yariv Keshet, Orly Gal-Or… in International Journal of Retina and Vitreo… (2021)

    Download PDF (1995 KB) View Article

  2. No Access

    Article

    Vismodegib improves quality of life in patients with periocular locally advanced basal cell carcinoma: subgroup analysis, STEVIE trial

    To evaluate the effect of locally advanced periocular basal cell carcinoma (POLA-BCC) on health-related quality of life (HRQoL) and the benefit of vismodegib treatment among participants in the Safety Events i...

    Assaf Gershoni, Alon Tiosano, Meydan Ben Ishai, Edward Barayev, Guy J. Ben Simon… in Eye (2022)

  3. No Access

    Article

    Limbal–conjunctival autograft healing process—early postoperative OCT angiography study

    To assess the normal healing process of limbal–conjunctival autograft (LCA) after pterygium removal during the early postoperative period using anterior segment optical coherence tomography angiography (OCTA).

    Yariv Keshet, Asaf Polat, Orly Gal-Or, Meydan Ben Ishai, Yotam Keshet… in Eye (2022)

  4. No Access

    Article

    The initial rate of tumour response to vismodegib treatment, can predict a complete response outcome for periocular LA-BCC

    To establish a model to predict treatment outcome of periocular locally advanced basal cell carcinoma (POLA BCC) based on initial response to treatment with vismodegib (ErivedgeTM), a sonic hedgehog inhibitor.

    Alon Tiosano, Meydan Ben-Ishai, Eyal Fenig, Guy J. Ben simon, Iftach Yassur in Eye (2023)

  5. No Access

    Article

    Primary cemiplimab treatment for orbital squamous cell carcinoma is effective and may alleviate the need for orbital exenteration

    To evaluate the effectiveness of cemiplimab, a Programmed-cell-death-1(PD-1) protein inhibitor, for the treatment of cutaneous periocular-locally-advanced squamous-cell-carcinoma (POLA-SCC) with orbital-invasion.

    Alon Tiosano, Meydan Ben-Ishai, Yaacov Cnaany, Gal Markel, Noga Kurman… in Eye (2023)

  6. Article

    Open Access

    Ocular injuries associated with motor vehicle accidents: long term effects on quality of life

    To describe the prevalence and outcome of motor vehicle accidents-associated ocular injuries.

    Judith Brody, Meydan Ben Ishai, Irena Serov-Volach… in International Ophthalmology (2024)

    Download PDF (403 KB) View Article